Exact Mass: 447.2383
Exact Mass Matches: 447.2383
Found 500 metabolites which its exact mass value is equals to given mass value 447.2383
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tyrosyl-prolyl-leucyl-glycinamide
Palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Ronacaleret
Tyr-pro-leu-gly-NH2
2-(2H-Benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol
(1S,3R,17S,19S)-3-Hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.01,17 03,15 04,13 07,12 019,23]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Thr Lys Ala Glu
C26H29N3O4_8H,10H-7a,12a-(Iminomethano)indolizino[6,7-h]pyrano[3,2-a]carbazole-8,16-dione, 3,6b,7,11,12,13,13a,14-octahydro-6b-hydroxy-3,3,14,14-tetramethyl-, (6bR,7aS,12aS,13aS)
(1S,3R,17S,19S)-3-hydroxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-4,6,10,12,14-pentaene-24,26-dione
Ala Ala Met Arg
Ala Ala Arg Met
Ala Cys Arg Val
Ala Cys Val Arg
Ala Glu Lys Thr
Ala Glu Thr Lys
Ala Lys Glu Thr
Ala Lys Met Val
Ala Lys Thr Glu
Ala Lys Val Met
Ala Met Ala Arg
Ala Met Lys Val
Ala Met Arg Ala
Ala Met Val Lys
Ala Arg Ala Met
Ala Arg Cys Val
Ala Arg Met Ala
Ala Arg Thr Thr
Ala Arg Val Cys
Ala Thr Glu Lys
Ala Thr Lys Glu
Ala Thr Arg Thr
Ala Thr Thr Arg
Ala Val Cys Arg
Ala Val Lys Met
Ala Val Met Lys
Ala Val Arg Cys
Cys Ala Arg Val
Cys Ala Val Arg
Cys Gly Ile Arg
Cys Gly Leu Arg
Cys Gly Arg Ile
Cys Gly Arg Leu
Cys Ile Gly Arg
Cys Ile Arg Gly
Cys Lys Val Val
Cys Leu Gly Arg
Cys Leu Arg Gly
Cys Arg Ala Val
Cys Arg Gly Ile
Cys Arg Gly Leu
Cys Arg Ile Gly
Cys Arg Leu Gly
Cys Arg Val Ala
Cys Val Ala Arg
Cys Val Lys Val
Cys Val Arg Ala
Cys Val Val Lys
Asp Lys Ser Val
Asp Lys Val Ser
Asp Ser Lys Val
Asp Ser Val Lys
Asp Val Lys Ser
Asp Val Ser Lys
Glu Ala Lys Thr
Glu Ala Thr Lys
Glu Lys Ala Thr
Glu Lys Thr Ala
Glu Thr Ala Lys
Glu Thr Lys Ala
Phe Gly Lys Pro
Phe Gly Pro Lys
Phe Lys Gly Pro
Phe Lys Pro Gly
Phe Pro Gly Lys
Phe Pro Lys Gly
Gly Cys Ile Arg
Gly Cys Leu Arg
Gly Cys Arg Ile
Gly Cys Arg Leu
Gly Phe Lys Pro
Gly Phe Pro Lys
Gly Ile Cys Arg
Gly Ile Lys Met
Gly Ile Met Lys
Gly Ile Arg Cys
Gly Lys Phe Pro
Gly Lys Ile Met
Gly Lys Leu Met
Gly Lys Met Ile
Gly Lys Met Leu
Gly Lys Pro Phe
Gly Leu Cys Arg
Gly Leu Lys Met
Gly Leu Met Lys
Gly Leu Arg Cys
Gly Met Ile Lys
Gly Met Lys Ile
Gly Met Lys Leu
Gly Met Leu Lys
Gly Pro Phe Lys
Gly Pro Lys Phe
Gly Arg Cys Ile
Gly Arg Cys Leu
Gly Arg Ile Cys
Gly Arg Leu Cys
Ile Cys Gly Arg
Ile Cys Arg Gly
Ile Gly Cys Arg
Ile Gly Lys Met
Ile Gly Met Lys
Ile Gly Arg Cys
Ile Lys Gly Met
Ile Lys Met Gly
Ile Met Gly Lys
Ile Met Lys Gly
Ile Asn Ala Met
Ile Asn Cys Val
Ile Asn Thr Thr
Ile Gln Ser Thr
Ile Gln Thr Ser
Ile Arg Cys Gly
Ile Arg Gly Cys
Ile Ser Gln Thr
Ile Ser Thr Gln
Ile Thr Asn Thr
Ile Thr Gln Ser
Ile Thr Ser Gln
Ile Thr Thr Asn
Lys Ala Glu Thr
Lys Ala Met Val
Lys Ala Thr Glu
Lys Ala Val Met
Lys Cys Val Val
Lys Asp Ser Val
Lys Asp Val Ser
Lys Glu Ala Thr
Lys Glu Thr Ala
Lys Phe Gly Pro
Lys Phe Pro Gly
Lys Gly Phe Pro
Lys Gly Ile Met
Lys Gly Leu Met
Lys Gly Met Ile
Lys Gly Met Leu
Lys Gly Pro Phe
Lys Ile Gly Met
Lys Ile Met Gly
Lys Leu Gly Met
Lys Leu Met Gly
Lys Met Ala Val
Lys Met Gly Ile
Lys Met Gly Leu
Lys Met Ile Gly
Lys Met Leu Gly
Lys Met Val Ala
Lys Pro Phe Gly
Lys Pro Gly Phe
Lys Ser Asp Val
Lys Ser Val Asp
Lys Thr Ala Glu
Lys Thr Glu Ala
Lys Val Ala Met
Lys Val Cys Val
Lys Val Asp Ser
Lys Val Met Ala
Lys Val Ser Asp
Lys Val Val Cys
Leu Cys Gly Arg
Leu Cys Arg Gly
Leu Gly Cys Arg
Leu Gly Lys Met
Leu Gly Met Lys
Leu Gly Arg Cys
Leu Lys Gly Met
Leu Lys Met Gly
Leu Met Gly Lys
Leu Met Lys Gly
Leu Asn Thr Thr
Leu Gln Ser Thr
Leu Gln Thr Ser
Leu Arg Cys Gly
Leu Arg Gly Cys
Leu Ser Gln Thr
Leu Ser Thr Gln
Leu Thr Asn Thr
Leu Thr Gln Ser
Leu Thr Ser Gln
Leu Thr Thr Asn
Met Ala Ala Arg
Met Ala Lys Val
Met Ala Arg Ala
Met Ala Val Lys
Met Gly Ile Lys
Met Gly Lys Ile
Met Gly Lys Leu
Met Gly Leu Lys
Met Ile Gly Lys
Met Ile Lys Gly
Met Lys Ala Val
Met Lys Gly Ile
Met Lys Gly Leu
Met Lys Ile Gly
Met Lys Leu Gly
Met Lys Val Ala
Met Leu Gly Lys
Met Leu Lys Gly
Met Arg Ala Ala
Met Val Ala Lys
Met Val Lys Ala
Asn Ile Thr Thr
Asn Leu Thr Thr
Asn Thr Ile Thr
Asn Thr Leu Thr
Asn Thr Thr Ile
Asn Thr Thr Leu
Pro Phe Gly Lys
Pro Phe Lys Gly
Pro Gly Phe Lys
Pro Gly Lys Phe
Pro Lys Phe Gly
Pro Lys Gly Phe
Gln Ile Ser Thr
Gln Ile Thr Ser
Gln Leu Ser Thr
Gln Leu Thr Ser
Gln Ser Ile Thr
Gln Ser Leu Thr
Gln Ser Thr Ile
Gln Ser Thr Leu
Gln Thr Ile Ser
Gln Thr Leu Ser
Gln Thr Ser Ile
Gln Thr Ser Leu
Gln Thr Thr Val
Gln Thr Val Thr
Gln Val Thr Thr
Arg Ala Ala Met
Arg Ala Cys Val
Arg Ala Met Ala
Arg Ala Thr Thr
Arg Ala Val Cys
Arg Cys Ala Val
Arg Cys Gly Ile
Arg Cys Gly Leu
Arg Cys Ile Gly
Arg Cys Leu Gly
Arg Cys Val Ala
Arg Gly Cys Ile
Arg Gly Cys Leu
Arg Gly Ile Cys
Arg Gly Leu Cys
Arg Ile Cys Gly
Arg Ile Gly Cys
Arg Leu Cys Gly
Arg Leu Gly Cys
Arg Met Ala Ala
Arg Ser Ser Val
Arg Ser Val Ser
Arg Thr Ala Thr
Arg Thr Thr Ala
Arg Val Ala Cys
Arg Val Cys Ala
Arg Val Ser Ser
Ser Asp Lys Val
Ser Asp Val Lys
Ser Ile Gln Thr
Ser Ile Thr Gln
Ser Lys Asp Val
Ser Lys Val Asp
Ser Leu Gln Thr
Ser Leu Thr Gln
Ser Gln Ile Thr
Ser Gln Leu Thr
Ser Gln Thr Ile
Ser Gln Thr Leu
Ser Arg Ser Val
Ser Arg Val Ser
Ser Ser Arg Val
Ser Ser Val Arg
Ser Thr Ile Gln
Ser Thr Leu Gln
Ser Thr Gln Ile
Ser Thr Gln Leu
Ser Val Asp Lys
Ser Val Lys Asp
Ser Val Arg Ser
Ser Val Ser Arg
Thr Ala Glu Lys
Thr Ala Lys Glu
Thr Ala Arg Thr
Thr Ala Thr Arg
Thr Glu Ala Lys
Thr Glu Lys Ala
Thr Ile Asn Thr
Thr Ile Gln Ser
Thr Ile Ser Gln
Thr Ile Thr Asn
Thr Lys Glu Ala
Thr Leu Asn Thr
Thr Leu Gln Ser
Thr Leu Ser Gln
Thr Leu Thr Asn
Thr Asn Ile Thr
Thr Asn Leu Thr
Thr Asn Thr Ile
Thr Asn Thr Leu
Thr Gln Ile Ser
Thr Gln Leu Ser
Thr Gln Ser Ile
Thr Gln Ser Leu
Thr Gln Thr Val
Thr Gln Val Thr
Thr Arg Ala Thr
Thr Arg Thr Ala
Thr Ser Ile Gln
Thr Ser Leu Gln
Thr Ser Gln Ile
Thr Ser Gln Leu
Thr Thr Ala Arg
Thr Thr Ile Asn
Thr Thr Leu Asn
Thr Thr Asn Ile
Thr Thr Asn Leu
Thr Thr Gln Val
Thr Thr Arg Ala
Thr Thr Val Gln
Thr Val Gln Thr
Thr Val Thr Gln
Val Ala Cys Arg
Val Ala Lys Met
Val Ala Met Lys
Val Ala Arg Cys
Val Cys Ala Arg
Val Cys Lys Val
Val Cys Arg Ala
Val Cys Val Lys
Val Asp Lys Ser
Val Asp Ser Lys
Val Lys Ala Met
Val Lys Cys Val
Val Lys Asp Ser
Val Lys Met Ala
Val Lys Ser Asp
Val Lys Val Cys
Val Met Ala Lys
Val Met Lys Ala
Val Gln Met Ala
Val Gln Thr Thr
Val Arg Ala Cys
Val Arg Cys Ala
Val Arg Ser Ser
Val Ser Asp Lys
Val Ser Lys Asp
Val Ser Arg Ser
Val Ser Ser Arg
Val Thr Gln Thr
Val Thr Thr Gln
Val Val Cys Lys
Val Val Lys Cys
Ronacaleret
C78281 - Agent Affecting Musculoskeletal System
H-DL-Tyr-DL-Pro-DL-Leu-Gly-NH2
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(8R)-8-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
9-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]nonanoic acid
palbociclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS